ZA883209B - A pharmaceutical combination for the prophylazis and therapy of malaria - Google Patents

A pharmaceutical combination for the prophylazis and therapy of malaria

Info

Publication number
ZA883209B
ZA883209B ZA883209A ZA883209A ZA883209B ZA 883209 B ZA883209 B ZA 883209B ZA 883209 A ZA883209 A ZA 883209A ZA 883209 A ZA883209 A ZA 883209A ZA 883209 B ZA883209 B ZA 883209B
Authority
ZA
South Africa
Prior art keywords
prophylazis
malaria
therapy
pharmaceutical combination
pharmaceutical
Prior art date
Application number
ZA883209A
Inventor
Kumar Chatterjee Dipak
Venugopalan Bindumadhavan
Lal Bansi
John De Souza Noel
Helmut Rupp Richard
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of ZA883209B publication Critical patent/ZA883209B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA883209A 1987-05-08 1988-05-05 A pharmaceutical combination for the prophylazis and therapy of malaria ZA883209B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715378 DE3715378A1 (en) 1987-05-08 1987-05-08 COMBINATION OF MEDICINES ON PROPHYLAXIS AND THERAPY FROM MALARIA

Publications (1)

Publication Number Publication Date
ZA883209B true ZA883209B (en) 1988-11-08

Family

ID=6327117

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883209A ZA883209B (en) 1987-05-08 1988-05-05 A pharmaceutical combination for the prophylazis and therapy of malaria

Country Status (11)

Country Link
EP (1) EP0290959A3 (en)
JP (1) JPS6452714A (en)
KR (1) KR880013558A (en)
AU (1) AU614515B2 (en)
DE (1) DE3715378A1 (en)
DK (1) DK249688A (en)
HU (1) HU200688B (en)
IL (1) IL86302A0 (en)
IN (1) IN166154B (en)
PT (1) PT87427B (en)
ZA (1) ZA883209B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
DE68906345T2 (en) * 1988-10-07 1993-10-28 Hoechst Ag Antimalarial compositions utilizing quinidine, artemisinin and their derivatives.
EP0535719A3 (en) * 1988-12-06 1993-04-14 Dermatologic Research Corporation Treatment of hemorrhoids with artemisinin and derivates
EP0464233A1 (en) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pharmaceutical combinations against malaria
JP3560970B2 (en) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト Antimalarial synergistic composition containing benzoflumetol
GB9622427D0 (en) * 1996-10-28 1997-01-08 Pharma Mar Sa Antimalarial drugs
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
IN191696B (en) * 1999-02-12 2003-12-20 Council Scient Ind Res
AU2000255627A1 (en) * 2000-03-28 2001-10-08 Council Of Scientific And Industrial Research A novel anti-microbial composition and method for producing the same
JPWO2002032905A1 (en) * 2000-10-20 2004-02-26 味の素株式会社 Pharmaceutical compositions, doses and methods for treating malaria
CN1255106C (en) 2003-09-26 2006-05-10 李国桥 Complex artemisia apiacea extract
WO2006070393A1 (en) * 2004-12-28 2006-07-06 Council Of Scientific And Industrial Research SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA
FR2884715B1 (en) * 2005-04-20 2007-06-15 Sanofi Aventis Sa ASSOCIATION BETWEEN FERROQUIN AND AN ARTEMISININE DERIVATIVE FOR THE TREATMENT OF MALARIA
WO2007043061A1 (en) * 2005-10-11 2007-04-19 Ipca Laboratories Ltd. Anti-malarial combination and methods of formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
DE68906345T2 (en) * 1988-10-07 1993-10-28 Hoechst Ag Antimalarial compositions utilizing quinidine, artemisinin and their derivatives.

Also Published As

Publication number Publication date
PT87427A (en) 1989-05-31
IL86302A0 (en) 1988-11-15
EP0290959A3 (en) 1990-03-07
HUT47846A (en) 1989-04-28
HU200688B (en) 1990-08-28
DK249688A (en) 1988-11-09
PT87427B (en) 1992-09-30
DE3715378A1 (en) 1988-11-24
AU614515B2 (en) 1991-09-05
AU1567588A (en) 1988-11-10
JPS6452714A (en) 1989-02-28
EP0290959A2 (en) 1988-11-17
DK249688D0 (en) 1988-05-06
IN166154B (en) 1990-03-24
KR880013558A (en) 1988-12-21

Similar Documents

Publication Publication Date Title
GB2205496B (en) Medicinal or therapeutic pack
CS403391A3 (en) Pharmaceutical
EP0196415A3 (en) Trichostatins a and c as antitumour drugs
ZA883209B (en) A pharmaceutical combination for the prophylazis and therapy of malaria
IL79900A0 (en) Combination preparations for the treatment of malaria
EP0305902A3 (en) Medicament
GB8819490D0 (en) Pharmaceutical devices
EP0412158A4 (en) Oncostatic drug
IE872788L (en) Pharmaceutical combination
GB8719374D0 (en) Pharmaceutical devices
GB8901158D0 (en) Administering drugs
IL82087A0 (en) Medicinal emulsions
GB8705553D0 (en) Medicament
EG18297A (en) New drug preparation
EG18240A (en) New pharmaceutical preparation
IE881376L (en) Anti-malarial pharmaceutical combination
GB8704637D0 (en) Pharmaceutical agents
ZA885842B (en) A device for the administration of implants
GB8707180D0 (en) Medicaments
GB8707178D0 (en) Medicaments
GB8727686D0 (en) Medicaments
GB8727687D0 (en) Medicaments
GB8727688D0 (en) Medicaments
GB8728140D0 (en) Medicaments
GB8728714D0 (en) Medicaments